The Margin The FDA’s list of toxic sanitizers is surging—now at 75. Here’s why The initial list back in June was for nine hand sanitizers but has surged in recent weeks amid an ongoing ...

Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The ...

The FDA has released an “initial batch“ of more than 200 complete response letters (CRLs) in efforts to boost transparency. The attempt may have created more questions, however, with only ...

SUN PRAIRIE, Wis. (WKOW) − A new state law set to take effect on September 1 could put hundreds of vape shops out of business. The law mandates that vaping products can only be sold if they are ...

GE HealthCare (Nasdaq: GEHC) has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to ...

(Reuters) -The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and longtime Stanford University professor, as the director of the ...

In the past, the FDA has pounced on drugmakers, such as a 2022 letter to the maker of Trulicity for not indicating the blood sugar-lowering drug was FDA approved for adults with type 2 diabetes.

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older against fleas and ticks.

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program ...

JUUL Products Authorized by FDA FDA issued MGOs for the on-market JUUL System, which is a closed, cartridge-based nicotine vapor product that utilizes proprietary heating technology to aerosolize ...

Attempting to eliminate funding for certain kinds of “woke” studies, the Trump administration erased hundreds of millions of dollars being used for cancer research.

It's shaping up to be a big year for Boehringer Ingelheim—at least if the FDA plays ball. The German drugmaker is awaiting the agency's decision on approving key therapies for lung cancer and ...